Vi­gene Bio­sciences goes big on Mary­land vi­ral vec­tor ex­pan­sion as it rides high on Al­tim­mune vac­cine deal

Boost­ed by a gang­busters year for Rockville-based Emer­gent BioSo­lu­tions and its vi­ral vec­tors for Covid-19 vac­cines, the state of Mary­land has con­tin­ued to ce­ment its place as a hotbed for next-gen man­u­fac­tur­ing. Now, a small­er play­er is look­ing to build out its own small foothold in the state.

Vi­gene Bio­sciences, al­so based in Rockville, has snagged a pub­lic-pri­vate part­ner­ship with the state of Mary­land and its home base of Mont­gomery Coun­ty to add 52,000 feet of man­u­fac­tur­ing space at its head­quar­ters site.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER